No significant differences in pain scores or presence of haze were seen in patients given two different concentrations of nepafenac ophthalmic suspension at two different frequencies after photorefractive keratectomy, according to a study.
The prospective study of 35 patients who underwent PRK were assigned to receive nepafenac 0.3% ophthalmic suspension once daily in one eye and nepafenac 0.1% ophthalmic suspension three times a day in the contralateral eye from the day of operation until reepithelialization.
Pain was evaluated every 2 hours on the day of the operation and once daily
Uncategorized